Cargando…
Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
BACKGROUND: Multicystic peritoneal mesothelioma (MCPM) is a rare neoplasm, generally considered a borderline malignancy, best treated by cytoreductive surgery (CRS) to remove macroscopic disease, combined with hyperthermic intraperitoneal chemotherapy (HIPEC). Owing to its rarity, little has been pu...
Autores principales: | Zahid, A, Clarke, L, Carr, N, Chandrakumaran, K, Tzivanakis, A, Dayal, S, Mohamed, F, Cecil, T, Moran, B J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944491/ https://www.ncbi.nlm.nih.gov/pubmed/33688945 http://dx.doi.org/10.1093/bjsopen/zraa001 |
Ejemplares similares
-
Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone
por: Mirnezami, R, et al.
Publicado: (2014) -
Multicystic peritoneal mesothelioma treated with complete cytoreductive surgery, peritonectomy and hyperthermic intra-peritoneal chemotherapy—A case report
por: Padmanabhan, Naveen, et al.
Publicado: (2020) -
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations
por: Enomoto, Laura M, et al.
Publicado: (2019) -
Fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): an observational study protocol
por: Taher, Rayan, et al.
Publicado: (2022) -
Benign multicystic mesothelioma of appendiceal origin treated by hyperthermic intraperitoneal chemotherapy: A case report
por: Lee, Suk Jun, et al.
Publicado: (2022)